Lung cancer: screening, diagnosis, and investigation - clinical fact sheet and MCQ
Overview
Lung cancer remains the leading cause of cancer-related mortality in Australia. Early detection significantly improves outcomes. Despite advancements in therapy, prognosis is strongly linked to stage at diagnosis—5-year survival is 68% for stage 1 disease, but just 3% at stage 4. However, symptoms are often non-specific, which can delay recognition and referral. Primary care clinicians are critical in initiating timely investigation and referral, especially given that many patients have multiple GP consultations prior to diagnosis.
Up to 10% of males and 35% of females diagnosed with lung cancer have never smoked, so it is vital to consider the diagnosis of lung cancer in non -smokers..
In July 2025, the new National lung cancer screening program commences, including new Medicare items and reporting requirements.
Lung cancer screening in primary practice
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas eu odio in nibh placerat tempor ac vel mauris. Nunc efficitur sapien at nisl semper dapibus. Nullam tempor eros sed dui aliquam lacinia. Nunc feugiat facilisis ex.
Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia curae; Maecenas mauris nibh, tempus sit amet erat vel, pellentesque maximus ipsum. Suspendisse dui nunc, porta ac ultricies id, sodales eu ante.
The Medcast medical education team is a group of highly experienced, practicing GPs, health professionals and medical writers.
Become a member and get unlimited access to 100s of hours of premium education.
Learn moreMedcast Medical Education Team
Women suffering from endometriosis often experience diagnostic delay. This FastTrack fact sheet provides a concise summary of the diagnosis and management of endometriosis, including the role of hormone therapy and indications for referral. 30min RP and 30min EA CPD available with the quiz.
Medcast Medical Education Team
From 1 Nov 2025, the Australian government is making important changes with the Bulk Billing Practice Incentive Program (BBPIP). This FastTrack is a concise summary of how to make the most of the BBPIP, from registration, eligibility considerations, and a step-by-step approach to preparing your practice for the changes.
Medcast Medical Education Team
Two of the four core palliative care medicines are clonazepam and haloperidol, used respectively to manage anxiety and emesis in end-of-life patients. This FastTrack highlights the role of the GP in treating these two common symptoms, focusing on pharmacological strategies. 30mins each of RP and EA CPD available with the quiz.